New Study Finds Fosamax May Increase Risk of Certain Types of Fractures
A new study regarding the potential risks associated with the use of the class of osteoporosis drugs referred to as bisphosphonates including Fosamax reveals that the drugs may increase the risk of so called “atypical” fractures.